Prediction of long-term survival in gastric cancer patients after immunotherapy based on CT-derived extracellular volume fraction
CT-derived ECV may serve as an independent predictor of long-term survival in gastric cancer patients undergoing immunotherapy.
Authors
- Shanshan Jiang (ORCID: https://orcid.org/0000-0003-3461-6076)
- Xiangchuang Kong (ORCID: https://orcid.org/0000-0001-5740-0425)
- Yuyang Wang (ORCID: https://orcid.org/0009-0000-2391-3599)
- Yi Li (ORCID: https://orcid.org/0000-0002-8876-0041)
- Zhiying Li (ORCID: https://orcid.org/0000-0003-3347-5486)
- Ziqiao Lei (ORCID: https://orcid.org/0000-0002-3103-4188)
- Yanjie Yang (ORCID: https://orcid.org/0000-0002-0481-9510)
- Guofeng Zhou
Institutions
- Precision for Medicine (United States) (US)
- Wuhan Union Hospital (CN)
- Union Hospital (CN)
- Hubei University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-28
- DOI
- https://doi.org/10.3389/fonc.2025.1698065
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00